Foster City, CA – According to filings with the U.S. Securities and Exchange Commission, MedGenome is raising $50,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Sam Santhosh played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About MedGenome
MedGenome Inc. is a genomics-based diagnostics and research company delivering the best of health care by decoding genetic information contained in an individuals genome.

To learn more about MedGenome, visit http://www.medgenome.com/

Contact:
Sam Santhosh, Chief Executive Officer
888-440-0954
sam.santhosh@medgenome.com

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved